MEDINA, OH/ABINGDON, UK – Green Biologics Inc., the U.S. subsidiary of Green Biologics Ltd., was named in the 2018 Global Cleantech 100, produced by Cleantech Group (CTG).
The Global Cleantech 100 represents the most innovative and promising ideas impacting the future of a wide range of industries. Featuring companies that are best positioned to solve tomorrow’s clean technology challenges, the Global Cleantech 100 is a comprehensive list of private companies with the highest potential to make significant market impact within a 5-10-year timeframe.
“Green Biologics is delighted to be among the recipients of this distinguished award,” said David Anderson, Global Vice President of Marketing, Green Biologics. “This recognition provides additional validation of our commitment to clean technology innovation and to our proprietary fermentation platform, which is being employed to efficiently and sustainably make high-performance n-butanol and acetone as well as their chemical derivatives. Manufacturers of coatings, pharmaceuticals, textiles, cosmetics and other products have shown great interest in using our acetone and n-butanol in unique ways to create consumer product goods that meet market demands.”
This list is collated by combining proprietary CTG research data, with weighted qualitative judgments from hundreds of nominations, and specific inputs from a global 86-person expert panel. To qualify for the list, companies must be independent, for-profit, clean-tech companies that are not listed on any major stock exchange.
Green Biologics Ltd. is a renewable specialty chemicals company based in Abingdon, England, with a wholly owned U.S. operating company, Green Biologics Inc., based in Ashland, Virginia. The company’s clostridium fermentation platform converts a wide range of sustainable feedstocks into high-performance green chemicals such as n-butanol, acetone, and through chemical synthesis, derivatives of n-butanol and acetone.